 In clinical trials, anti-factor therapy resulted in a 26.8% increase in mitochondrial function, restoring it to levels found in young adults. Anti-factor has also been shown to reduce fatigue by up to 43%. It has even been shown to significantly reduce a wide range of symptoms and improve the quality of life in patients with various conditions, like chronic fatigue and those undergoing chemotherapy.